Patent Applications published on Jun 21, 2018 - page 4

#901
US20180168991A1
Human necessities

STYLING AGENT WITH IMPROVED LONG-TERM HOLD AND DEGREE OF HOLD

#902 ✅ Patent 11,229,594 granted on 2022-01-25
US20180168992A1
Human necessities

Oil-in-water emulsion composition

#903
US20180168993A1
Human necessities

Oral Care Compositions

#904 ✅ Patent 10,660,420 granted on 2020-05-26
US20180168994A1
Human necessities

Cosmetic compositions

#905
US20180168995A1
Human necessities

Particles With Cross-Linked Coatings For Cosmetic Applications

#906
US20180168996A1
Human necessities

Method of Conditioning the Hair

#907
US20180168997A1
Human necessities

HAIR CONDITIONING COMPOSITION

#908 ✅ Patent 10,322,079 granted on 2019-06-18
US20180168998A1
Human necessities

Hair dye

#909 ✅ Patent 11,147,302 granted on 2021-10-19
US20180168999A1
Human necessities

Use of a combination of taurine or a derivate thereof and a grape extract for improving the quality of the nails

#910
US20180169000A1
Human necessities

DYING AGENT USING NATURAL HENNA

#911 ✅ Patent 10,342,757 granted on 2019-07-09
US20180169001A1
Human necessities

Cytomimetic formulations and methods of manufacturing the same

#912 ✅ Patent 10,485,752 granted on 2019-11-26
US20180169002A1
Human necessities

Skin rejuvenation and defense systems and methods

#913 ✅ Patent 10,300,010 granted on 2019-05-28
US20180169003A1
Human necessities

Methods for delivering entanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

#914 ✅ Patent 10,471,007 granted on 2019-11-12
US20180169004A1
Human necessities

Sublingual therapeutic solutions and methods

#915
US20180169005A1
Human necessities

METHODS FOR ADMINISTERING ARIPIPRAZOLE

#916
US20180169006A1
Human necessities

CO-PACKAGED DRUG PRODUCTS

#917
US20180169007A1
Human necessities

Methods of Anesthetizing Nerve Tissue in the Trigeminal Nerve Pathway and Medical Uses Thereof

#918 ✅ Patent 10,117,831 granted on 2018-11-06
US20180169008A1
Human necessities

Soft chew pharmaceutical formulations

#919
US20180169009A1
Human necessities

NANOBIOCOMPOSITE COMPOSITIONS AND METHODS

#920
US20180169010A1
Human necessities

LONG ACTING LIRAGLUTIDE COMPOSITIONS

#921 ✅ Patent 10,117,832 granted on 2018-11-06
US20180169011A1
Human necessities

Emulsified fatty acids

#922 ✅ Patent 12,064,510 granted on 2024-08-20
US20180169012A1
Human necessities

Medical foam for delivery of an active agent

#923 ✅ Patent 11,000,476 granted on 2021-05-11
US20180169013A1
Human necessities

Cavitation seed for drug delivery, and drug delivery method using same

#924 ✅ Patent 10,722,508 granted on 2020-07-28
US20180169014A1
Human necessities

Liposomes useful for drug delivery

#925 ✅ Patent 10,137,086 granted on 2018-11-27
US20180169015A1
Human necessities

Lipid-derived neutral nanoparticles

#926 ✅ Patent 10,137,087 granted on 2018-11-27
US20180169016A1
Human necessities

Lipid-derived neutral nanoparticles

#927
US20180169017A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING PROLIFERATIVE DISEASES

#928
US20180169018A1
Human necessities

Method for improving the dissolution profile of a biologically active material

#929
US20180169019A1
Human necessities

PROCESS FOR THE PREPARATION OF POROUS MICROPARTICLES

#930 ✅ Patent 10,507,183 granted on 2019-12-17
US20180169020A1
Human necessities

Cleavable lipids

#931
US20180169021A1
Human necessities

RANOLAZINE MULTIPLE COMPRESSED TABLETS

#932 ✅ Patent 11,147,771 granted on 2021-10-19
US20180169022A1
Human necessities

Orodispersible dosage unit containing an estetrol component

#933 ✅ Patent 10,010,508 granted on 2018-07-03
US20180169023A1
Human necessities

MTAB-TA-Coated gold nanorods and method of fabrication

#934
US20180169024A1
Human necessities

MECHANO-SENSITIVE MICROCAPSULES FOR DRUG DELIVERY

#935 ✅ Patent 10,159,651 granted on 2018-12-25
US20180169025A1
Human necessities

Two-stage microparticle-based therapeutic delivery system and method

#936 ✅ Patent 10,058,512 granted on 2018-08-28
US20180169026A1
Human necessities

Rumen protected glucose and method of preparation

#937 ✅ Patent 11,224,577 granted on 2022-01-18
US20180169027A1
Human necessities

Treating infection by a platelet-targeting microbe using nanoparticles

#938
US20180169028A1
Human necessities

Nanoparticle Composition and Methods for Synthesis Thereof

#939 ✅ Patent 10,874,622 granted on 2020-12-29
US20180169029A1
Human necessities

Dual assembly nanoparticles

#940
US20180169030A1
Human necessities

DRUG CARRIER AND METHOD OF FABRICATING THE SAME

#941 ✅ Patent 11,357,737 granted on 2022-06-14
US20180169031A1
Human necessities

Chitosan nanofibers containing bioactive compounds

#942 ✅ Patent 10,898,446 granted on 2021-01-26
US20180169032A1
Human necessities

Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces

#943 ✅ Patent 10,828,265 granted on 2020-11-10
US20180169033A1
Human necessities

Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery

#944
US20180169034A1
Human necessities

TRANSDERMAL DELIVERY FORMULATION

#945
US20180169035A1
Human necessities

TERPENE-ENRICHED CANNABINOID COMPOSITION

#946 ✅ Patent 10,245,235 granted on 2019-04-02
US20180169036A1
Human necessities

Compositions and methods for treating muscular dystrophy and other disorders

#947 ✅ Patent 11,413,255 granted on 2022-08-16
US20180169037A1
Human necessities

Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles

#948
US20180169038A1
Human necessities

USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME

#949 ✅ Patent 10,653,647 granted on 2020-05-19
US20180169039A1
Human necessities

Methods and compositions for administration of TRPV1 agonists

#950 ✅ Patent 10,213,397 granted on 2019-02-26
US20180169040A1
Human necessities

Microtubule polymerization modulators for treating LMNA-related dilated cardiomyopathy

#951
US20180169041A1
Human necessities

COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL DISC-RELATED PAIN

#952 ✅ Patent 11,234,949 granted on 2022-02-01
US20180169042A1
Human necessities

Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy

#953
US20180169043A1
Human necessities

COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF HEPATIC STEATOSIS

#954
US20180169044A1
Human necessities

AMINO ACID COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES

#955 ✅ Patent 10,238,617 granted on 2019-03-26
US20180169045A1
Human necessities

Amino acid compositions and methods for the treatment of liver diseases

#956
US20180169046A1
Human necessities

AMINO ACID COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE DISEASES AND DISORDERS

#957
US20180169047A1
Human necessities

AMINO ACID COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE DISEASES AND DISORDERS

#958 ✅ Patent 10,966,947 granted on 2021-04-06
US20180169048A1
Human necessities

Combination therapy comprising an omega-3 fatty acid, a folate species and a vitamin B12 species

#959 ✅ Patent 10,272,060 granted on 2019-04-30
US20180169049A1
Human necessities

Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof

#960 ✅ Patent 10,188,623 granted on 2019-01-29
US20180169050A1
Human necessities

Enhanced bioavailability of polyunsaturated fatty acids

#961 ✅ Patent 10,188,624 granted on 2019-01-29
US20180169051A1
Human necessities

Enteric soft capsules comprising polyunsaturated fatty acids

#962
US20180169052A1
Human necessities

AGENT FOR IMPROVING BRAIN FUNCTION AND AGENT FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT

#963 ✅ Patent 10,258,593 granted on 2019-04-16
US20180169053A1
Human necessities

Semiochemical compositions to reduce social conflicts with cats

#964 ✅ Patent 10,258,594 granted on 2019-04-16
US20180169054A1
Human necessities

Cat appeasing pheromone

#965 ✅ Patent 10,980,768 granted on 2021-04-20
US20180169055A1
Human necessities

Composition containing carboplatin and use

#966 ✅ Patent 10,166,212 granted on 2019-01-01
US20180169056A1
Human necessities

Oral use of zinc and copper gluconates in the treatment of digital dermatitis

#967
US20180169057A1
Human necessities

TREATMENT OF INFLAMMATORY LESIONS IN SUBJECTS AFFLICTED WITH MODERATE TO SEVERE ACNE

#968 ✅ Patent 10,507,195 granted on 2019-12-17
US20180169058A1
Human necessities

Taxane particles and their use

#969 ✅ Patent 11,617,734 granted on 2023-04-04
US20180169059A1
Human necessities

Enantiomers of A2-73, analogues, and sigma agonist activity

#970 ✅ Patent 10,413,519 granted on 2019-09-17
US20180169060A1
Human necessities

Crystal forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions

#971
US20180169061A1
Human necessities

NON-AQUEOUS DELTA9-TETRAHYDROCANNABINOL ORAL LIQUID FORMULATIONS

#972
US20180169062A1
Human necessities

Palladium Lipoic Acid Complex Formulation As An Adjunct In Radiotherapy

#973 ✅ Patent 10,058,534 granted on 2018-08-28
US20180169063A1
Human necessities

Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders

#974
US20180169064A1
Human necessities

AZIRIDINE CONTAINING DNA ALKYLATING AGENTS

#975 ✅ Patent 10,709,685 granted on 2020-07-14
US20180169065A1
Human necessities

Use of methadone metabolites for treatment of anxiety and depression

#976 ✅ Patent 10,632,102 granted on 2020-04-28
US20180169066A1
Human necessities

Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof

#977
US20180169067A1
Human necessities

COMBINATION DRUG THERAPIES FOR CANCER AND METHODS OF MAKING AND USING THEM

#978 ✅ Patent 11,617,737 granted on 2023-04-04
US20180169068A1
Human necessities

Compositions and methods that modulate vitamin D and bone mineral content in a companion animal

#979
US20180169069A1
Human necessities

COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA

#980
US20180169070A1
Human necessities

DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO

#981
US20180169071A1
Human necessities

NUTRITIONAL SUPPLEMENT COMPOSITION

#982 ✅ Patent 10,357,481 granted on 2019-07-23
US20180169072A1
Human necessities

Substituted triazolo bicyclic compounds as PDE2 inhibitors

#983
US20180169073A1
Human necessities

ISOXAZOLINE SOLUTION CONTAINING VITAMIN E FOR USE WITH SANITIZED DRINKING WATER

#984 ✅ Patent 10,238,639 granted on 2019-03-26
US20180169074A1
Human necessities

Azophenols as ERG oncogene inhibitors

#985 ✅ Patent 10,617,678 granted on 2020-04-14
US20180169075A1
Human necessities

Treatment of restenosis using temsirolimus

#986 ✅ Patent 10,576,065 granted on 2020-03-03
US20180169076A1
Human necessities

Pharmaceutical composition containing rifaximin alpha and delta

#987 ✅ Patent 10,675,275 granted on 2020-06-09
US20180169077A1
Human necessities

Prophylactic and/or therapeutic agent for fibromyalgia

#988 ✅ Patent 10,758,522 granted on 2020-09-01
US20180169078A1
Human necessities

Small molecule analogs of the nemo binding peptide

#989 ✅ Patent 10,179,127 granted on 2019-01-15
US20180169079A1
Human necessities

Pharmaceutical formulations comprising a pyridylaminoacetic acid compound

#990 ✅ Patent 11,992,482 granted on 2024-05-28
US20180169080A1
Human necessities

Malleable controlled release local anesthetic with hemostatic composition

#991 ✅ Patent 10,702,512 granted on 2020-07-07
US20180169081A1
Human necessities

Treatment of debilitating fatigue

#992
US20180169082A1
Human necessities

DONEPEZIL COMPOSITIONS AND METHODS OF TREATING ALZHEIMERS DISEASE

#993
US20180169083A1
Human necessities

INHIBITORS OF NUCLEOTIDYL TRANSFERASES AND USE IN HERPES AND HEPATITIS VIRAL INFECTIONS THEREFOR

#994
US20180169084A1
Human necessities

Methods of Administering Pirfenidone Therapy

#995
US20180169085A1
Human necessities

Combination Therapy for Hemorrhagic Injury

#996 ✅ Patent 10,702,515 granted on 2020-07-07
US20180169086A1
Human necessities

Compositions containing aromatic aldehydes and their use in treatments

#997
US20180169087A1
Human necessities

BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2

#998 ✅ Patent 10,206,917 granted on 2019-02-19
US20180169088A1
Human necessities

Aqueous drug

#999 ✅ Patent 10,596,166 granted on 2020-03-24
US20180169089A1
Human necessities

Combination composition comprising huperzine

#1000
US20180169090A1
Human necessities

ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM

#1001 ✅ Patent 10,195,193 granted on 2019-02-05
US20180169091A1
Human necessities

Levocetirizine and montelukast in the treatment of inflammation mediated conditions

#1002
US20180169092A1
Human necessities

PHARMACEUTICAL FORMULATIONS FOR TREATING GLAUCOMA AND METHODS FOR FABRICATING AND USING THEREOF

#1003 ✅ Patent 10,632,115 granted on 2020-04-28
US20180169093A1
Human necessities

Use of a statin compound as local drug for treating obesity, diabetes, hypertension and hyperlipemia

#1004 ✅ Patent 10,314,841 granted on 2019-06-11
US20180169094A1
Human necessities

Substituted pyrazoles as IRAK inhibitors

#1005
US20180169095A1
Human necessities

THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC)

#1006 ✅ Patent 10,238,657 granted on 2019-03-26
US20180169096A1
Human necessities

Heterocyclic compounds for treating psoriasis

#1007 ✅ Patent 10,702,527 granted on 2020-07-07
US20180169097A1
Human necessities

Combination therapy of transcription inhibitors and kinase inhibitors

#1008 ✅ Patent 10,603,321 granted on 2020-03-31
US20180169098A1
Human necessities

Small molecules targeting HIV-1 nef

#1009
US20180169099A1
Human necessities

HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

#1010
US20180169100A1
Human necessities

Cancer Stem Cell Targeting Compounds

#1011
US20180169101A1
Human necessities

METHODS FOR TREATING CANCER

#1012 ✅ Patent 10,485,802 granted on 2019-11-26
US20180169102A1
Human necessities

Composition for inducing differentiation and protection of neural stem cells and method for inducing neuro-regeneration using the same composition

#1013 ✅ Patent 10,653,698 granted on 2020-05-19
US20180169103A1
Human necessities

Methods of improving myocardial performance in Fontan patients using udenafil compositions

#1014 ✅ Patent 10,238,661 granted on 2019-03-26
US20180169104A1
Human necessities

Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections

#1015 ✅ Patent 10,576,086 granted on 2020-03-03
US20180169105A1
Human necessities

Triazine derivatives as interferon-gamma inhibitors

#1016
US20180169106A1
Human necessities

CEFTOLOZANE-TAZOBACTAM PHARMACEUTICAL COMPOSITIONS

#1017 ✅ Patent 10,688,103 granted on 2020-06-23
US20180169107A1
Human necessities

Methods for treating hypersomnia

#1018
US20180169108A1
Human necessities

Drug Combinations For the Treatment of HIV

#1019 ✅ Patent 11,046,954 granted on 2021-06-29
US20180169109A1
Human necessities

Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses

#1020 ✅ Patent 10,272,095 granted on 2019-04-30
US20180169110A1
Human necessities

NRF2 regulators

#1021 ✅ Patent 10,869,874 granted on 2020-12-22
US20180169111A1
Human necessities

Methods and compositions for topical delivery of prostaglandins to subcutaneous fat

#1022 ✅ Patent 10,835,540 granted on 2020-11-17
US20180169112A1
Human necessities

Pharmaceutical use

#1023 ✅ Patent 10,603,327 granted on 2020-03-31
US20180169113A1
Human necessities

High concentration formulation

#1024 ✅ Patent 10,195,215 granted on 2019-02-05
US20180169114A1
Human necessities

Methods for reducing cellular proliferation and treating certain diseases

#1025 ✅ Patent 10,071,108 granted on 2018-09-11
US20180169115A1
Human necessities

Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection

#1026 ✅ Patent 10,172,872 granted on 2019-01-08
US20180169116A1
Human necessities

Treatment of otitis media with retroauricular injection of an anti-inflammatory drug

#1027
US20180169117A1
Human necessities

PHARMACEUTICAL FORMULATION COMPRISING A SUBSTITUTED PHENYL - (1,3-DIHYDRO-ISOINDOL-2-YL) - METHANONE

#1028 ✅ Patent 10,258,636 granted on 2019-04-16
US20180169118A1
Human necessities

Prodrug salts

#1029 ✅ Patent 10,463,682 granted on 2019-11-05
US20180169119A1
Human necessities

Compositions for oral administration of zoledronic acid or related compounds for treating low back pain

#1030
US20180169120A1
Human necessities

COMBINATION THERAPY INCLUDING SAPC-DOPS FOR THE TREATMENT OF PANCREATIC CANCER

#1031
US20180169121A1
Human necessities

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

#1032 ✅ Patent 11,026,959 granted on 2021-06-08
US20180169122A1
Human necessities

Synthetic composition and method for treating irritable bowel syndrome

#1033
US20180169123A1
Human necessities

COMBINATION THERAPY WITH A FLAVAGLINE AND 2-DEOXYGLUCOSE

#1034
US20180169124A1
Human necessities

SUSTAINED RELEASE OF ANTIINFECTIVES

#1035
US20180169125A1
Human necessities

COMPOSITIONS OF MULTICATIONIC DRUGS FOR REDUCING INTERACTIONS WITH POLYANIONIC BIOMOLECULES AND METHODS OF USE THEREOF

#1036
US20180169126A1
Human necessities

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1037 ✅ Patent 11,291,680 granted on 2022-04-05
US20180169127A1
Human necessities

Compositions and methods that modulate white blood cells or neutrophils in a companion animal

#1038
US20180169128A1
Human necessities

IMMUNOASSAY OF S-ADENOSYLMETHIONINE USING ANALOGS THEREOF AND PERSONALIZED THERAPEUTICS

#1039 ✅ Patent 10,709,728 granted on 2020-07-14
US20180169129A1
Human necessities

Polynucleotide agents targeting angiotensinogen (AGT) and methods of use thereof

#1040 ✅ Patent 10,471,089 granted on 2019-11-12
US20180169130A1
Human necessities

Combined therapy for duchenne muscular dystrophy

#1041 ✅ Patent 10,426,789 granted on 2019-10-01
US20180169131A1
Human necessities

Allele specific modulators of P23H rhodopsin

#1042
US20180169132A1
Human necessities

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#1043 ✅ Patent 10,842,809 granted on 2020-11-24
US20180169133A1
Human necessities

Pet food compositions

#1044 ✅ Patent 10,632,143 granted on 2020-04-28
US20180169134A1
Human necessities

Chitosan materials from carbonic acid solution

#1045
US20180169135A1
Human necessities

METHOD FOR PREVENTING TRANSPLANT FAILURE IN A HOST

#1046
US20180169136A1
Human necessities

USE OF PHARMACEUTICAL COMPOSITION IN PREPARATION OF DRUG FOR PROMOTING CHONDROCYTE GENERATION

#1047 ✅ Patent 11,141,426 granted on 2021-10-12
US20180169137A1
Human necessities

Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration

#1048 ✅ Patent 10,314,859 granted on 2019-06-11
US20180169138A1
Human necessities

Use of gastrointestinally administered porous enteron sorbent polymers to prevent or treat radiation induced mucositis, esophagitis, enteritis, colitis, and gastrointestinal acute radiation syndrome

#1049
US20180169139A1
Human necessities

COMPOSITION AND METHODS FOR TREATMENT OF LOSS OF FLUIDS LEADING TO HYPOTENSION AND/OR HYPOVOLEMIA

#1050
US20180169140A1
Human necessities

ANTIBIOTIC COMPOSITIONS AND METHODS OF USE

#1051 ✅ Patent 11,020,425 granted on 2021-06-01
US20180169141A1
Human necessities

Injectable hydrogels that promote mineralization and afford sustained release of bioactive ions

#1052
US20180169142A1
Human necessities

METHODS, MEANS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF SURGICAL INTERVENTIONS AND INFLAMMATORY SEQUEL

#1053 ✅ Patent 10,555,969 granted on 2020-02-11
US20180169143A1
Human necessities

Zeolite molecular sieves for the removal of toxins

#1054 ✅ Patent 10,258,645 granted on 2019-04-16
US20180169144A1
Human necessities

Citrate containing beverage

#1055
US20180169145A1
Human necessities

COMPOSITIONS AND METHODS FOR USING LAMELLAR BODIES FOR THERAPEUTIC PURPOSES

#1056 ✅ Patent 11,000,547 granted on 2021-05-11
US20180169146A1
Human necessities

Compositions related to rna in circularized form

#1057 ✅ Patent 11,166,983 granted on 2021-11-09
US20180169147A1
Human necessities

Methods for the production of TCRγδ T cells

#1058 ✅ Patent 10,350,245 granted on 2019-07-16
US20180169148A1
Human necessities

Point-of-care and/or portable platform for gene therapy

#1059
US20180169149A1
Human necessities

OXYGENATED DEMINERALIZED BONE MATRIX FOR USE IN BONE GROWTH

#1060 ✅ Patent 10,369,173 granted on 2019-08-06
US20180169150A1
Human necessities

Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy

#1061 ✅ Patent 10,967,008 granted on 2021-04-06
US20180169151A1
Human necessities

Pharmaceutical compositions and topical use thereof

#1062 ✅ Patent 10,668,109 granted on 2020-06-02
US20180169152A1
Human necessities

Conditioning protocols and use of same for tissue regeneration

#1063
US20180169153A1
Human necessities

PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR TREATMENT AND PREVENTION OF GRAFT VERSES HOST DISEASE

#1064 ✅ Patent 10,933,102 granted on 2021-03-02
US20180169154A1
Human necessities

Bacteria engineered to treat a disease or disorder

#1065 ✅ Patent 11,806,315 granted on 2023-11-07
US20180169155A1
Human necessities

Compositions and methods for small canines

#1066 ✅ Patent 10,695,385 granted on 2020-06-30
US20180169156A1
Human necessities

Oral cancer vaccine

#1067 ✅ Patent 10,064,904 granted on 2018-09-04
US20180169157A1
Human necessities

Treatment of infection

#1068 ✅ Patent 10,617,727 granted on 2020-04-14
US20180169158A1
Human necessities

Treatment for gastroesophageal reflux disease caused by a neurological disorder

#1069
US20180169159A1
Human necessities

CANCER TREATMENT AND DIAGNOSIS

#1070 ✅ Patent 10,155,016 granted on 2018-12-18
US20180169160A1
Human necessities

Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

#1071
US20180169161A1
Human necessities

EUGLENA DERIVED COMPOSITION HAVING IMMUNE RESPONSE INDUCING COMPONENTS

#1072
US20180169162A1
Human necessities

Method of Producing Cannabidiol Derived Products

#1073 ✅ Patent 10,722,546 granted on 2020-07-28
US20180169163A1
Human necessities

Methods for treating neurological disorders using nutrient compositions

#1074 ✅ Patent 10,624,941 granted on 2020-04-21
US20180169164A1
Human necessities

Method for regulating expressions of gene, gene, gene and/or gene by using extract

#1075
US20180169165A1
Human necessities

JATROPHA CURCAS PROCESSING METHOD AND PRODUCTS

#1076
US20180169166A1
Human necessities

COMPOSITION FOR INHIBITING AND PREVENTING MYOPATHY, CONTAINING BEAN LEAF EXTRACT AS ACTIVE INGREDIENT

#1077 ✅ Patent 10,391,136 granted on 2019-08-27
US20180169167A1
Human necessities

Lentil consumption reduces artery remodeling and restores arterial compliance

#1078 ✅ Patent 10,568,922 granted on 2020-02-25
US20180169168A1
Human necessities

Anticancer composition containing mixed herbal medicine extract as active ingredient

#1079
US20180169169A1
Human necessities

HERBAL COMPOSITION FOR TREATMENT OF BACK PAIN

#1080 ✅ Patent 10,258,660 granted on 2019-04-16
US20180169170A1
Human necessities

Olive leaf extract and method of producing the same

#1081 ✅ Patent 10,967,031 granted on 2021-04-06
US20180169171A1
Human necessities

Synergistic herbal compositions with prebiotic properties for treatment of skin infections, allergies and inflammation

#1082
US20180169172A1
Human necessities

COMPOUND AND METHOD FOR REDUCING APPETITE, FATIGUE AND PAIN

#1083 ✅ Patent 11,260,099 granted on 2022-03-01
US20180169173A1
Human necessities

Pet food compositions

#1084 ✅ Patent 10,471,116 granted on 2019-11-12
US20180169174A1
Human necessities

Botanical formulation for treating sickle cell disease

#1085 ✅ Patent 10,758,587 granted on 2020-09-01
US20180169175A1
Human necessities

Formulations for the treatment of disorders of the mouth, throat and respiratory tract

#1086 ✅ Patent 10,772,926 granted on 2020-09-15
US20180169176A1
Human necessities

Natural drugs for the treatment of inflammation and melanoma

#1087
US20180169177A1
Human necessities

POLYPEPTIDE SPECIFICALLY BINDING TO CD34 MOLECULE AND USE THEREOF

#1088 ✅ Patent 10,456,441 granted on 2019-10-29
US20180169178A1
Human necessities

Augmenting the immune response by promoting cell death of immune cells

#1089
US20180169179A1
Human necessities

COMPOSITION FOR IMPROVING MEMORY, LEARNING ABILITY, AND COGNITIVE ABILITY

#1090
US20180169180A1
Human necessities

MICAFUNGIN COMPOSITIONS

#1091 ✅ Patent 10,456,442 granted on 2019-10-29
US20180169181A1
Human necessities

FGF receptor ligands for treating diabetes and obesity

#1092 ✅ Patent 10,603,353 granted on 2020-03-31
US20180169182A1
Human necessities

Recombinant clostridial neurotoxins with increased duration of effect

#1093
US20180169183A1
Human necessities

DUAL SIGNALING PROTEIN (DSP) FUSION PROTEINS, AND METHODS OF USING THEREOF FOR TREATING DISEASES

#1094
US20180169184A1
Human necessities

Inhibitor of IGFBP3/TMEM219 Axis and Diabetes

#1095 ✅ Patent 10,485,849 granted on 2019-11-26
US20180169185A1
Human necessities

Syndecan peptides and polypeptides as inhibitors of vascular endothelial growth factor receptor-2 (VEGFR2) and very late antigen-4 (VLA-4)

#1096 ✅ Patent 10,702,580 granted on 2020-07-07
US20180169186A1
Human necessities

Beta-casein A2 and antioxidant capacity

#1097
US20180169187A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALNUTRITION

#1098 ✅ Patent 10,426,819 granted on 2019-10-01
US20180169188A1
Human necessities

Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein

#1099 ✅ Patent 10,869,911 granted on 2020-12-22
US20180169189A1
Human necessities

Chimeric protein

#1100
US20180169190A1
Human necessities

INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS

#1101
US20180169191A1
Human necessities

ADRENOCORTICOTROPIC HORMONE-BASED PHARMACEUTICAL FORMULATIONS AND METHODS FOR FABRICATING AND USING THEREOF

#1102 ✅ Patent 10,258,671 granted on 2019-04-16
US20180169192A1
Human necessities

Compositions and methods for treating platelet storage pool deficiency, gray platelet syndrome and quebec platelet disorder

#1103
US20180169193A1
Human necessities

METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION

#1104 ✅ Patent 11,298,411 granted on 2022-04-12
US20180169194A1
Human necessities

Methods and compositions for RNA-guided treatment of HIV infection

#1105
US20180169195A1
Human necessities

METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION

#1106 ✅ Patent 10,568,946 granted on 2020-02-25
US20180169196A1
Human necessities

Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes

#1107 ✅ Patent 10,842,854 granted on 2020-11-24
US20180169197A1
Human necessities

Agent for use in the case of fructose intolerance

#1108 ✅ Patent 10,328,137 granted on 2019-06-25
US20180169198A1
Human necessities

Compositions and methods of enhancing immune responses to or limiting infection

#1109 ✅ Patent 10,537,626 granted on 2020-01-21
US20180169199A1
Human necessities

HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell

#1110 ✅ Patent 11,191,820 granted on 2021-12-07
US20180169200A1
Human necessities

Method for inducing early T memory response with short peptides anti-tumor vaccine

#1111 ✅ Patent 10,117,920 granted on 2018-11-06
US20180169201A1
Human necessities

Combination of vaccination and inhibition of the PD-1 pathway

#1112 ✅ Patent 10,434,158 granted on 2019-10-08
US20180169202A1
Human necessities

Combination of vaccination and inhibition of the PD-1 pathway

#1113 ✅ Patent 10,617,750 granted on 2020-04-14
US20180169203A1
Human necessities

Partner of SLD five 1 (PSF1)-derived peptide

#1114 ✅ Patent 10,603,369 granted on 2020-03-31
US20180169204A1
Human necessities

Combination vaccines with lower doses of antigen and/or adjuvant

#1115
US20180169205A1
Human necessities

HYBRID FLAGELLIN AS A T CELL INDEPENDENT VACCINE SCAFFOLD

#1116
US20180169206A1
Human necessities

Immunogenic compositions

#1117 ✅ Patent 10,434,163 granted on 2019-10-08
US20180169207A1
Human necessities

Remedy for bovine leukemia prophylaxis and use thereof

#1118 ✅ Patent 10,188,716 granted on 2019-01-29
US20180169208A1
Human necessities

Protective antigen complexes with increased stability and uses thereof

#1119 ✅ Patent 10,391,161 granted on 2019-08-27
US20180169209A1
Human necessities

FSBM recombinant protein

#1120
US20180169210A1
Human necessities

HYBRID AND TANDEM EXPRESSION OF NEISSERIAL PROTEINS

#1121
US20180169211A1
Human necessities

Peptides derived from acinetobacter baumannii and their use in vaccination

#1122 ✅ Patent 10,646,562 granted on 2020-05-12
US20180169212A1
Human necessities

Glycosylation method

#1123 ✅ Patent 10,624,963 granted on 2020-04-21
US20180169213A1
Human necessities

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

#1124 ✅ Patent 10,576,142 granted on 2020-03-03
US20180169214A1
Human necessities

PCV2 immunogenic compositions and methods of producing such compositions

#1125 ✅ Patent 11,160,857 granted on 2021-11-02
US20180169215A1
Human necessities

Multivalent enterovirus vaccine compositions and uses related thereto

#1126 ✅ Patent 10,363,300 granted on 2019-07-30
US20180169216A1
Human necessities

FMDV and E2 fusion proteins and uses thereof

#1127 ✅ Patent 10,258,686 granted on 2019-04-16
US20180169217A1
Human necessities

Materials and methods for respiratory disease control in canines

#1128 ✅ Patent 10,799,577 granted on 2020-10-13
US20180169218A1
Human necessities

Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen

#1129 ✅ Patent 10,300,131 granted on 2019-05-28
US20180169219A1
Human necessities

Hepatitis C virus immunogenic compositions and methods of use thereof

#1130
US20180169220A1
Human necessities

ALLERGY-SPECIFIC IMMUNOTHERAPY COMPOSITIONS FOR USE IN THE TREATMENT OF HOUSE-DUST MITE ALLERGY

#1131 ✅ Patent 10,799,579 granted on 2020-10-13
US20180169221A1
Human necessities

Methods for enhancing antigen-specific immune responses

#1132 ✅ Patent 10,624,964 granted on 2020-04-21
US20180169222A1
Human necessities

Methods and compositions for stimulating immune response using potent immunostimulatory RNA motifs

#1133 ✅ Patent 11,110,167 granted on 2021-09-07
US20180169223A1
Human necessities

Vaccine adjuvant composition comprising inulin particles

#1134
US20180169224A1
Human necessities

TLR AGONISTS FOR REDUCING ACTIVATION-INDUCED PD-1 EXPRESSION ON T CELLS AND METHODS OF USE

#1135 ✅ Patent 10,517,947 granted on 2019-12-31
US20180169225A1
Human necessities

Methods for preparing squalene

#1136
US20180169226A1
Human necessities

Vaccine Composition Containing Synthetic Adjuvant

#1137 ✅ Patent 11,278,616 granted on 2022-03-22
US20180169227A1
Human necessities

Immunity induction promoting composition, and vaccine pharmaceutical composition

#1138 ✅ Patent 10,456,466 granted on 2019-10-29
US20180169228A1
Human necessities

Anti-VEGF antibody

#1139 ✅ Patent 10,751,412 granted on 2020-08-25
US20180169229A1
Human necessities

Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer

#1140
US20180169230A1
Human necessities

COMBINATION CANCER THERAPIES

#1141 ✅ Patent 10,857,229 granted on 2020-12-08
US20180169231A1
Human necessities

Treatment of ovarian cancer in patients with ascites using a specific binding agent of human angiopoietin-2 in combination with a taxane

#1142 ✅ Patent 10,869,924 granted on 2020-12-22
US20180169232A1
Human necessities

PD-L1 antagonist combination treatments

#1143 ✅ Patent 10,206,999 granted on 2019-02-19
US20180169233A1
Human necessities

Antibodies against LIF and uses thereof

#1144
US20180169234A1
Human necessities

Method of Treating Alvelor Bone Loss Through The Use of Anti-Sclerostin Antibodies

#1145 ✅ Patent 10,799,583 granted on 2020-10-13
US20180169235A1
Human necessities

Treatment for bone diseases

#1146 ✅ Patent 10,724,103 granted on 2020-07-28
US20180169236A1
Human necessities

Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapy

#1147 ✅ Patent 11,376,326 granted on 2022-07-05
US20180169237A1
Human necessities

GPC3-targeting therapeutic agent which is administered to patient for whom the GPC3-targeting therapeutic agent is effective

#1148 ✅ Patent 10,124,061 granted on 2018-11-13
US20180169238A1
Human necessities

Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof

#1149
US20180169239A1
Human necessities

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

#1150
US20180169240A1
Human necessities

METHODS OF TREATING AUTOIMMUNE AND ALLOIMMUNE DISORDERS

#1151 ✅ Patent 11,298,420 granted on 2022-04-12
US20180169241A1
Human necessities

Armed oncolytic viruses

#1152
US20180169242A1
Human necessities

PHARMACEUTICAL COMBINATION FOR CANCER TREATMENT AND THE THERAPEUTIC USE THEREOF

#1153
US20180169243A1
Human necessities

STICK-SHAPED BASE MATERIAL COMPRISING LIPID PEPTIDE COMPOUND

#1154 ✅ Patent 10,105,444 granted on 2018-10-23
US20180169244A1
Human necessities

Compositions and methods for treating diseases of the nail

#1155 ✅ Patent 10,391,178 granted on 2019-08-27
US20180169245A1
Human necessities

Premix of crystalline raltegravir potassium salt and a process for the preparation thereof

#1156 ✅ Patent 10,111,958 granted on 2018-10-30
US20180169246A1
Human necessities

Anti-CD40 antibody formulation

#1157 ✅ Patent 10,576,156 granted on 2020-03-03
US20180169247A1
Human necessities

Compositions for drug administration

#1158 ✅ Patent 10,660,960 granted on 2020-05-26
US20180169248A1
Human necessities

Ophthalmic drug delivery system containing phospholipid and cholesterol

#1159 ✅ Patent 10,449,256 granted on 2019-10-22
US20180169249A1
Human necessities

Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer

#1160 ✅ Patent 10,772,965 granted on 2020-09-15
US20180169250A1
Human necessities

Covalent linkers in antibody-drug conjugates and methods of making and using the same

#1161 ✅ Patent 10,195,285 granted on 2019-02-05
US20180169251A1
Human necessities

AGTR1 aptamer-anticancer drug complex for cancer cell chemotherapy

#1162 ✅ Patent 10,420,845 granted on 2019-09-24
US20180169252A1
Human necessities

Taggable heteroaromatic drugs and conjugates thereof

#1163
US20180169253A1
Human necessities

Means and Methods for Treatment of B-Cell Malignancies

#1164 ✅ Patent 10,441,663 granted on 2019-10-15
US20180169254A1
Human necessities

Methods for treating cancer

#1165 ✅ Patent 10,744,204 granted on 2020-08-18
US20180169255A1
Human necessities

Conjugated compounds comprising cysteine-engineered antibodies

#1166 ✅ Patent 11,123,439 granted on 2021-09-21
US20180169256A1
Human necessities

Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups

#1167 ✅ Patent 11,351,269 granted on 2022-06-07
US20180169257A1
Human necessities

Anti-NTB-A antibodies and related compositions and methods

#1168 ✅ Patent 10,722,594 granted on 2020-07-28
US20180169258A1
Human necessities

Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

#1169
US20180169259A1
Human necessities

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES

#1170 ✅ Patent 10,881,744 granted on 2021-01-05
US20180169260A1
Human necessities

Glycan-dependent immunotherapeutic molecules

#1171 ✅ Patent 10,912,842 granted on 2021-02-09
US20180169261A1
Human necessities

CD123 antibodies and conjugates thereof

#1172 ✅ Patent 10,864,279 granted on 2020-12-15
US20180169262A1
Human necessities

Linker-drug and antibody-drug conjugate (ADC) employing the same

#1173 ✅ Patent 10,556,017 granted on 2020-02-11
US20180169263A1
Human necessities

Lipid-based drug carriers for rapid penetration through mucus linings

#1174 ✅ Patent 10,736,972 granted on 2020-08-11
US20180169264A1
Human necessities

Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis

#1175 ✅ Patent 10,155,051 granted on 2018-12-18
US20180169265A1
Human necessities

Carrier nanoparticles and related compositions, methods and systems

#1176
US20180169266A1
Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#1177
US20180169267A1
Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#1178 ✅ Patent 10,383,952 granted on 2019-08-20
US20180169268A1
Human necessities

Ionizable cationic lipid for RNA delivery

#1179 ✅ Patent 11,027,024 granted on 2021-06-08
US20180169269A1
Human necessities

Methods of delivery of transgenes for treating brain diseases

#1180 ✅ Patent 11,129,907 granted on 2021-09-28
US20180169270A1
Human necessities

Self-assembled ribonucleoprotein nanoparticles

#1181
US20180169271A1
Human necessities

ARMED REPLICATION-COMPETENT ONCOLYTIC ADENOVIRUSES

#1182 ✅ Patent 10,617,771 granted on 2020-04-14
US20180169272A1
Human necessities

Adenoassociated virus vectors for the treatment of mucopolysaccharidoses

#1183 ✅ Patent 10,286,087 granted on 2019-05-14
US20180169273A1
Human necessities

Immunoadsorption

#1184 ✅ Patent 10,137,209 granted on 2018-11-27
US20180169274A1
Human necessities

Gadolinium chelate compounds for use in magnetic resonance imaging

#1185
US20180169275A1
Human necessities

POLYMERIC MICELLAR NANOPARTICLES

#1186 ✅ Patent 10,842,890 granted on 2020-11-24
US20180169276A1
Human necessities

Contrast agent and associated methods

#1187 ✅ Patent 10,245,331 granted on 2019-04-02
US20180169277A1
Human necessities

Cromolyn derivatives and related methods of imaging and treatment

#1188 ✅ Patent 10,568,979 granted on 2020-02-25
US20180169278A1
Human necessities

Treatment system for cleaning a component, in particular an implant part, contaminated with a biofilm

#1189
US20180169279A1
Human necessities

APPARATUS, METHOD AND SYSTEM FOR SELECTIVELY AFFECTING AND/OR KILLING A VIRUS

#1190 ✅ Patent 11,000,608 granted on 2021-05-11
US20180169280A1
Human necessities

Ultraviolet lamp room/area disinfection apparatuses having integrated cooling systems

#1191
US20180169281A1
Human necessities

LIQUID OR GEL DELIVERY DEVICES

#1192 ✅ Patent 10,485,889 granted on 2019-11-26
US20180169282A1
Human necessities

Sterilizing case

#1193 ✅ Patent 10,307,499 granted on 2019-06-04
US20180169283A1
Human necessities

Devices, systems and methods for zone sterilization

#1194
US20180169284A1
Human necessities

GAS SUPPLY TARGET DEVICE, GAS SUPPLY SYSTEM, AND METHOD OF CONTROLLING GAS SUPPLY SYSTEM

#1195
US20180169285A1
Human necessities

HIGH-PRESSURE SPRAY OZONE DISINFECTING OF INDUSTRIAL MANUFACTURING AND STORAGE TANKS

#1196 ✅ Patent 10,258,706 granted on 2019-04-16
US20180169286A1
Human necessities

Sterilization container capable of providing an indication regarding whether or not surgical instruments sterilized in the container were properly sterilized

#1197
US20180169287A1
Human necessities

AIR-CONDITIONING DEVICE

#1198 ✅ Patent 10,537,653 granted on 2020-01-21
US20180169288A1
Human necessities

Fragrance cartridge and chamber dispersion system

#1199
US20180169289A1
Human necessities

ATOMIZING ASSEMBLY AND ATOMIZER HAVING THE SAME

#1200 ✅ Patent 10,383,970 granted on 2019-08-20
US20180169290A1
Human necessities

Ion generator mounting device